TOP
| 2000 September | Sino Biopharmaceutical Limited was listed on the Growth Enterprise Market (GEM) of The Stock Exchange of Hong Kong Limited (Stock Code: 0827) |
| 2003 December | Sino Biopharmaceutical Ltd was successfully moved to the Main Board of The Stock Exchange of Hong Kong Limited (Stock Code: 1177) |
| 2005 July | Sino Biopharmaceutical Ltd Sold one of the Group’s subsidiaries Shandong Chia Tai Freda Pharmaceutical Co., Ltd to Bausch & Lomb for US$200 Million |
| 2011 December | The Company entered into the medical healthcare business by founding Chia Tai Shaoyang Orthopedic Hospital |
| 2013 June | Sino Biopharmaceutical Limited entered the health food market by holding Tianjin Zhenwutang Food Co., Ltd. |
| 2014 November | Sino Biopharmaceutical Limited made its presence in Europe by investing a stake in Karolinska Development AB |
| 2017 December | Sino Biopharmaceutical Limited's market capital (Stock Code: 1177) surpassed HK$100 Billion. |
| 2018 August | Sino Biopharmaceutical Limited was selected as a constituent stock of the Hang Seng Index. |